Vaginitis: Diagnosis and Treatment

Kamini Geer, MD, MPH
Ann Klega, MD

American Family Physician. 2025;112(5):504-512.

Author disclosure: Dr. Geer has disclosed serving as a speaker and Nexplanon trainer for Organon. Dr. Klega has no relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Vaginitis is a general term for inflammation of the vagina with symptoms such as vulvovaginal itching, burning, irritation, dyspareunia, odor, or abnormal vaginal discharge. It is a common condition that results in 5 million to 10 million office visits annually. The leading infectious causes of vaginitis are bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. Noninfectious causes include atrophic, irritant, and inflammatory vaginitis. Bacterial vaginosis usually presents with a thin, homogenous vaginal discharge and a fishy odor. Vulvovaginal candidiasis often manifests with a white, thick, curd-like discharge, pruritus, and vulvar erythema. Trichomoniasis usually presents with a green or yellow frothy discharge, and speculum examination may reveal cervical erythema with petechiae. Noninfectious vaginitis can present with clear or purulent discharge and can be pruritic depending on the etiology. Bacterial vaginosis can be diagnosed using Amsel criteria, Gram stain, or a nucleic acid amplification test (NAAT). Vulvovaginal candidiasis can be diagnosed by visualization of yeast hyphae or budding yeast on microscopy, vaginal fungal culture, polymerase chain reaction testing, or NAAT. Trichomoniasis can be diagnosed with visualization of motile, flagellated protozoa on saline microscopy, NAAT, or DNA probe test. Bacterial vaginosis is treated with oral or intravaginal metronidazole or intravaginal clindamycin. Vulvovaginal candidiasis is managed with topical or oral antifungals. Trichomoniasis is treated with oral metronidazole or tinidazole. When treating trichomoniasis, testing for reinfection, as well as other sexually transmitted infections, is recommended. Treatments for noninfectious vaginitis include vaginal lubricants and moisturizers, topical hormones, and topical steroids, depending on the cause.

KAMINI GEER, MD, MPH, is associate program director at the AdventHealth Family Medicine Residency Program in Winter Park, Florida, and an assistant professor at the Loma Linda University School of Medicine third-year core site in Orlando.

ANN KLEGA, MD, is program director at the Advent-Health Family Medicine Residency Program in Winter Park and an assistant professor at the Loma Linda University School of Medicine third-year core site in Orlando.

Address correspondence to Kamini Geer, MD, MPH, at kamini.geer.md@adventhealth.com.

Author disclosure: Dr. Geer has disclosed serving as a speaker and Nexplanon trainer for Organon. Dr. Klega has no relevant financial relationships.

  1. 1.Vaginitis in nonpregnant patients. ACOG practice bulletin, number 215. Obstet Gynecol. 2020;135(1):e1-e17.
  2. 2.Paladine HL, Desai UA. Vaginitis: diagnosis and treatment. Am Fam Physician. 2018;97(5):321-329.
  3. 3.Paavonen J, Brunham RC. Bacterial vaginosis and desquamative inflammatory vaginitis. N Engl J Med. 2018;379(23):2246-2254.
  4. 4.Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291(11):1368-1379.
  5. 5.Bilardi JE, Walker S, Temple-Smith M, et al. The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One. 2013;8(9):e74378.
  6. 6.Karasz A, Anderson M. The vaginitis monologues: women’s experiences of vaginal complaints in a primary care setting. Soc Sci Med. 2003;56(5):1013-1021.
  7. 7.Ehrström S, Kornfeld D, Rylander E. Perceived stress in women with recurrent vulvovaginal candidiasis. J Psychosom Obstet Gynaecol. 2007;28(3):169-176.
  8. 8.Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137.
  9. 9.Hainer BL, Gibson MV. Vaginitis. Am Fam Physician. 2011;83(7):807-815.
  10. 10.Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
  11. 11.Anderson M, Cohrssen A, Klink K, et al. Are a speculum examination and wet mount always necessary for patients with vaginal symptoms? A pilot randomized controlled trial. J Am Board Fam Med. 2009;22(6):617-624.
  12. 12.Muzny CA, Cerca N, Elnaggar JH, et al. State of the art for diagnosis of bacterial vaginosis. J Clin Microbiol. 2023;61(8):e0083722.
  13. 13.Khan Z, Bhargava A, Mittal P, et al. Evaluation of reliability of self-collected vaginal swabs over physician-collected samples for diagnosis of bacterial vaginosis, candidiasis and trichomoniasis, in a resource-limited setting: a cross-sectional study in India. BMJ Open. 2019;9(8):e025013.
  14. 14.Camus C, Penaranda G, Khiri H, et al. Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: a cross-sectional study. PLoS One. 2021;16(11):e0260021.
  15. 15.Troeger KA, Thiel ER, London RS. Optimizing vaginitis diagnosis to reduce health care costs in nonpregnant women utilizing molecular diagnostics. Popul Health Manag. 2022;25(4):449-454.
  16. 16.Kissinger PJ, Gaydos CA, Seña AC, et al. Diagnosis and management of Trichomonas vaginalis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74(suppl 2):S152-S161.
  17. 17.Van Gerwen OT, Smith SE, Muzny CA. Bacterial vaginosis in postmenopausal women. Curr Infect Dis Rep. 2023;25(1):7-15.
  18. 18.Muzny CA, Balkus J, Mitchell C, et al. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74(suppl 2):S144-S151.
  19. 19.Barry K, Ceccarelli RBD. Max vaginal panel for the detection of vaginitis. Am Fam Physician. 2023;108(3):309-310.
  20. 20.Nyirjesy P, Brookhart C, Lazenby G, et al. Vulvovaginal candidiasis: a review of the evidence for the 2021 Centers for Disease Control and Prevention of sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74(suppl 2):S162-S168.
  21. 21.Nyirjesy P. Management of persistent vaginitis. Obstet Gynecol. 2014;124(6):1135-1146.
  22. 22.Vodstrcil LA, Plummer EL, Fairley CK, et al.; StepUp Team. Male-partner treatment to prevent recurrence of bacterial vaginosis. N Engl J Med. 2025;392(10):947-957.
  23. 23.Centers for Disease Control and Prevention. STI treatment (tx) guide mobile app. Accessed January 18, 2024. https://www.cdc.gov/std/treatment-guidelines/provider-resources.htm
  24. 24.Fjeld H, Raknes G. Is combining metronidazole and alcohol really hazardous? [Article in Norwegian]. Tidsskr Nor Laegeforen. 2014;134(17):1661-1663.
  25. 25.Bunge KE, Beigi RH, Meyn LA, et al. The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis. 2009;36(11):711-713.
  26. 26.Silver BJ, Guy RJ, Kaldor JM, et al. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41(6):369-376.
  27. 27.Yang S, Zhao W, Wang H, et al. Trichomonas vaginalis infection-associated risk of cervical cancer: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018;228:166-173.
  28. 28.Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36(1):11-16.
  29. 29.American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. Female sexual dysfunction: ACOG practice bulletin, number 213. Obstet Gynecol. 2019;134(1):e1-e18.
  30. 30.Sobel JD, Reichman O, Misra D, et al. Prognosis and treatment of desquamative inflammatory vaginitis. Obstet Gynecol. 2011;117(4):850-855.
  31. 31.Owen MK, Clenney TL. Management of vaginitis. Am Fam Physician. 2004;70(11):2125-2132.
  32. 32.Egan ME, Lipsky MS. Diagnosis of vaginitis. Am Fam Physician. 2000;62(5):1095-1104.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.